JP2022521705A5 - - Google Patents

Info

Publication number
JP2022521705A5
JP2022521705A5 JP2021547303A JP2021547303A JP2022521705A5 JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5 JP 2021547303 A JP2021547303 A JP 2021547303A JP 2021547303 A JP2021547303 A JP 2021547303A JP 2022521705 A5 JP2022521705 A5 JP 2022521705A5
Authority
JP
Japan
Prior art keywords
sequence
sequence number
antigen
sequences
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021547303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521705A (ja
JP7612591B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017518 external-priority patent/WO2020167668A1/en
Publication of JP2022521705A publication Critical patent/JP2022521705A/ja
Publication of JP2022521705A5 publication Critical patent/JP2022521705A5/ja
Priority to JP2024229509A priority Critical patent/JP7875933B2/ja
Application granted granted Critical
Publication of JP7612591B2 publication Critical patent/JP7612591B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021547303A 2019-02-11 2020-02-10 抗clec2d抗体及びその使用方法 Active JP7612591B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024229509A JP7875933B2 (ja) 2019-02-11 2024-12-25 抗clec2d抗体及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201941005395 2019-02-11
IN201941005395 2019-02-11
PCT/US2020/017518 WO2020167668A1 (en) 2019-02-11 2020-02-10 Anti-clec2d antibodies and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024229509A Division JP7875933B2 (ja) 2019-02-11 2024-12-25 抗clec2d抗体及びその使用方法

Publications (3)

Publication Number Publication Date
JP2022521705A JP2022521705A (ja) 2022-04-12
JP2022521705A5 true JP2022521705A5 (cg-RX-API-DMAC7.html) 2023-02-20
JP7612591B2 JP7612591B2 (ja) 2025-01-14

Family

ID=69811875

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021547303A Active JP7612591B2 (ja) 2019-02-11 2020-02-10 抗clec2d抗体及びその使用方法
JP2024229509A Active JP7875933B2 (ja) 2019-02-11 2024-12-25 抗clec2d抗体及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024229509A Active JP7875933B2 (ja) 2019-02-11 2024-12-25 抗clec2d抗体及びその使用方法

Country Status (9)

Country Link
US (2) US11827710B2 (cg-RX-API-DMAC7.html)
EP (1) EP3924385A1 (cg-RX-API-DMAC7.html)
JP (2) JP7612591B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220007584A (cg-RX-API-DMAC7.html)
AU (1) AU2020222891B2 (cg-RX-API-DMAC7.html)
CA (1) CA3129818A1 (cg-RX-API-DMAC7.html)
IL (1) IL285401A (cg-RX-API-DMAC7.html)
SG (1) SG11202108403UA (cg-RX-API-DMAC7.html)
WO (1) WO2020167668A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220007584A (ko) 2019-02-11 2022-01-18 주무토르 바이오로직스 인코포레이티드 항-clec2d 항체 및 이의 사용 방법
CN115443140A (zh) * 2020-04-02 2022-12-06 苏州恒康生命科学有限公司 人ror-1抗体和抗ror-1-car-t细胞
US20230374142A1 (en) * 2020-10-05 2023-11-23 Monash University CLEC9A antibodies
CN116997561A (zh) * 2021-03-24 2023-11-03 森永乳业株式会社 肽及含有该肽作为有效成分的组合物
US20240398902A1 (en) * 2021-09-13 2024-12-05 Achelois Biopharma, Inc. Multivalent interferon particles compositions and methods of use
CN114685663B (zh) * 2022-04-07 2023-09-08 西南大学 一种抗胆固醇依赖性细胞溶素的抗体及其应用
WO2023233330A1 (en) * 2022-05-31 2023-12-07 Pfizer Inc. Anti-bmp9 antibodies and methods of use thereof
KR20250122456A (ko) * 2022-11-01 2025-08-13 프로비던스 헬스 앤드 서비시즈 - 오레곤 Fas 리간드에 특이적인 단일클론 항체 및 이의 용도
CN115894675B (zh) * 2023-02-03 2023-11-14 康复大学(筹) 新冠病毒SARS-CoV-2核衣壳蛋白单克隆抗体及其应用
AU2024263454A1 (en) * 2023-04-24 2025-12-11 Elpis Biopharmaceuticals Armored anti-b7h3 car-t cells and uses thereof in cancer therapy
WO2025096542A2 (en) * 2023-10-30 2025-05-08 Immunitas Therapeutics, Inc. Clec2d binding proteins and related methods
WO2026050637A1 (en) * 2024-08-29 2026-03-05 Elpis Biopharmaceuticals Chimeric antigen receptor targeting interleukin- 13 receptor subunit alpha-2 and optionally b7h3 for treating glioblastoma
WO2026064353A1 (en) * 2024-09-17 2026-03-26 The Board Of Regents Of The University Of Texas System Diagnostics and therapeutics targeting slc13a3

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
JPH10501681A (ja) 1994-02-22 1998-02-17 ダナ−ファーバー キャンサー インスティチュート 核酸送達システムならびにその合成および使用方法
US7147854B2 (en) 1997-06-23 2006-12-12 Yes Biotech Laboratories Ltd. Topical treatment of psoriasis using neutralizing antibodies to interleukin-8
US20040001804A1 (en) * 1999-12-30 2004-01-01 Mathew Porunelloor A. LLT uses thereof in immune system modulation
WO2012000994A1 (en) * 2010-06-29 2012-01-05 C.N.R.S. Llt-1 antibodies with new functional properties
US9111624B2 (en) 2013-03-22 2015-08-18 Katsuyuki Fujita Semiconductor memory device
KR20220007584A (ko) * 2019-02-11 2022-01-18 주무토르 바이오로직스 인코포레이티드 항-clec2d 항체 및 이의 사용 방법

Similar Documents

Publication Publication Date Title
JP7098629B2 (ja) 抗pd-1モノクローナル抗体、その製造方法及び用途
TWI769537B (zh) 標靶bcma的抗體、雙專一性抗體及其用途
JP2022008382A5 (cg-RX-API-DMAC7.html)
CA3222764A1 (en) Anti-ccr8 antibodies and uses thereof
HRP20210739T1 (hr) Molekule koje vežu antigen i sadrže trimer obitelji tnf liganada
CN112574307A (zh) 抗人Claudin18.2抗体及其应用
CN114206931B (zh) 抗pd-1抗体及其用途
TWI777056B (zh) 結合至ssea4的單株抗體及其用途
JP2020510422A5 (cg-RX-API-DMAC7.html)
PH12020551173A1 (en) Anti-pd-l1 antibodies and uses thereof
RU2019128134A (ru) Антитело против gprc5d и молекула, содержащая антитело
JP2022504802A5 (cg-RX-API-DMAC7.html)
JP2018523493A5 (cg-RX-API-DMAC7.html)
RU2018106452A (ru) Поливалетные и полиспецифичные gitr-связывающие слитые белки
JP2018503380A5 (cg-RX-API-DMAC7.html)
JP2018518540A5 (cg-RX-API-DMAC7.html)
US20240101675A1 (en) Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof
JP2012501670A5 (cg-RX-API-DMAC7.html)
CN108164600B (zh) 一种抗gpc3抗体及其制备方法和用途
JP2020514277A5 (cg-RX-API-DMAC7.html)
JP2024530451A (ja) 抗pvrig/抗tigit二重特異性抗体及び応用
JP2013527762A5 (cg-RX-API-DMAC7.html)
CA3069238A1 (en) Bispecific antibodies and methods of making and using thereof
JP2023511898A5 (cg-RX-API-DMAC7.html)
JP2021501575A5 (cg-RX-API-DMAC7.html)